Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Express Scripts
AstraZeneca
McKinsey
Colorcon

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,579,019

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,579,019
Title:Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
Abstract:The present invention relates to a pharmaceutical delivery device for application of a pharmaceutical to mucosal surfaces. The device comprises an adhesive layer and a non-adhesive backing layer, and the pharmaceutical may be provided in either or both layers. Upon application, the device adheres to the mucosal surface, providing localized drug delivery and protection to the treatment site. The kinetics of erodability are easily adjusted by varying the number of layers and/or the components.
Inventor(s): Tapolsky; Gilles H. (The Woodlands, TX), Osborne; David W. (The Woodlands, TX)
Assignee: Arius Two, Inc. (Raleigh, NC)
Application Number:11/069,089
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,579,019
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Device;

Drugs Protected by US Patent 7,579,019

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-001 Oct 23, 2015 RX Yes No   Start Trial   Start Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE   Start Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-002 Oct 23, 2015 RX Yes No   Start Trial   Start Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE   Start Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-003 Oct 23, 2015 RX Yes No   Start Trial   Start Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE   Start Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-004 Oct 23, 2015 RX Yes No   Start Trial   Start Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE   Start Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-005 Oct 23, 2015 RX Yes No   Start Trial   Start Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE   Start Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-006 Oct 23, 2015 RX Yes No   Start Trial   Start Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE   Start Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-007 Oct 23, 2015 RX Yes Yes   Start Trial   Start Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,579,019

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 229322   Start Trial
Austria 288743   Start Trial
Australia 3892401   Start Trial
Australia 3967899   Start Trial
Australia 4757497   Start Trial
Australia 729516   Start Trial
Australia 746339   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Express Scripts
Merck
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.